Search research articles
Contact Us
Filters
Showing results (71-80 of 85) with videos related to
Page
of 9
Sort By:
Journal of the Peripheral Nervous System : JPNS
|
October 10, 2023
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome
Pieter A van Doorn, Peter Y K Van den Bergh, Robert D M Hadden, et al.
European Journal of Neurology
|
October 10, 2023
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome
Pieter A van Doorn, Peter Y K Van den Bergh, Robert D M Hadden, et al.
Brain Communications
|
January 12, 2023
Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2-4
Marloes Stam, Camiel A Wijngaarde, Bart Bartels, et al.
European Journal of Neurology
|
September 5, 2024
Patient-reported daily functioning after SARS-CoV-2 vaccinations in autoimmune neuromuscular diseases
Koos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
May 28, 2018
Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: Real world experience from 27 centres
Christoph Neuwirth, Nathalie Braun, Kristl G Claeys, et al.
Neurology. Clinical Practice
|
April 12, 2021
Facial Onset Sensory and Motor Neuronopathy: New Cases, Cognitive Changes, and Pathophysiology
Eva M J de Boer, Andrew W Barritt, Marwa Elamin, et al.
Brain Communications
|
September 21, 2020
<i>ATXN1</i> repeat expansions confer risk for amyotrophic lateral sclerosis and contribute to TDP-43 mislocalization
Gijs H P Tazelaar, Steven Boeynaems, Mathias De Decker, et al.
BMC Medicine
|
March 3, 2022
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases
Luuk Wieske, Laura Y L Kummer, Koos P J van Dam, et al.
Journal of Autoimmunity
|
January 9, 2023
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
Koos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
BMC Infectious Diseases
|
May 17, 2023
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity
Koos P J van Dam, Adriaan G Volkers, Luuk Wieske, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 85) with videos related to
Sort By:
Page
of 9
Journal of the Peripheral Nervous System : JPNS
|
October 10, 2023
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome
Pieter A van Doorn, Peter Y K Van den Bergh, Robert D M Hadden, et al.
European Journal of Neurology
|
October 10, 2023
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome
Pieter A van Doorn, Peter Y K Van den Bergh, Robert D M Hadden, et al.
Brain Communications
|
January 12, 2023
Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2-4
Marloes Stam, Camiel A Wijngaarde, Bart Bartels, et al.
European Journal of Neurology
|
September 5, 2024
Patient-reported daily functioning after SARS-CoV-2 vaccinations in autoimmune neuromuscular diseases
Koos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
May 28, 2018
Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: Real world experience from 27 centres
Christoph Neuwirth, Nathalie Braun, Kristl G Claeys, et al.
Neurology. Clinical Practice
|
April 12, 2021
Facial Onset Sensory and Motor Neuronopathy: New Cases, Cognitive Changes, and Pathophysiology
Eva M J de Boer, Andrew W Barritt, Marwa Elamin, et al.
Brain Communications
|
September 21, 2020
<i>ATXN1</i> repeat expansions confer risk for amyotrophic lateral sclerosis and contribute to TDP-43 mislocalization
Gijs H P Tazelaar, Steven Boeynaems, Mathias De Decker, et al.
BMC Medicine
|
March 3, 2022
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases
Luuk Wieske, Laura Y L Kummer, Koos P J van Dam, et al.
Journal of Autoimmunity
|
January 9, 2023
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
Koos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
BMC Infectious Diseases
|
May 17, 2023
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity
Koos P J van Dam, Adriaan G Volkers, Luuk Wieske, et al.
Page
of 9